Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Activation of MYC Pathway Is a Unifying Pathological Event in the Progression from Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma (MM).

Wee J. Chng, MD, Marta Chesi, PhD, Tammy Price-Troska, Greg Ahmann, Kim Henderson, Philip Greipp, MD, Robert Kyle, MD, S. Vincent Rajkumar, MD, Morie Gertz, MD, Rafael Fonseca, MD, P. Leif Bergsagel, MD

Blood (2007) 110 (11): 241.

https://doi.org/10.1182/blood.V110.11.241.241

Published: 2007

Journal Articles

A Randomized Trial of Lenalidomide Plus High-Dose Dexamethasone (RD) Versus Lenalidomide Plus Low-Dose Dexamethasone (Rd) in Newly Diagnosed Multiple Myeloma (E4A03): A Trial Coordinated by the Eastern Cooperative Oncology Group.

S. Vincent Rajkumar, MD, Susanna Jacobus, MS, Natalie Callander, MD, Rafael Fonseca, MD, David Vesole, MD, PhD, Michael Williams, MD, Rafat Abonour, MD, David Siegel, MD, Philip Greipp, MD

Blood (2007) 110 (11): 74.

https://doi.org/10.1182/blood.V110.11.74.74

Published: 2007

Journal Articles

Combined High Resolution Array Comparative Genomic Hybridization and Gene Expression Profiling Reveal Rb1 Haploinsufficiency as a Possibile Tumorigenic Mechanism in Myeloma.

Wee-Joo Chng, MD, Angela Baker, PhD, Travis Henry, PhD, Tammy Price-Troska, Scott Van Wier, Tae-Hoon Chung, PhD, Kim Henderson, Gregory Ahmann, Martha Lacy, MD, Angela Dispenzieri, MD, Morie Abraham Gertz, MD, Philip Greipp, MD, Peter Leif Bergsagel, MD, John Carpten, PhD, Rafael Fonseca, MD

Blood (2006) 108 (11): 113.

https://doi.org/10.1182/blood.V108.11.113.113

Published: 2006

Journal Articles

High Resolution Array CGH Identifies TRAF3 as a Novel Tumor Suppressor in Multiple Myeloma.

Blood (2006) 108 (11): 3407.

https://doi.org/10.1182/blood.V108.11.3407.3407

Published: 2006

Journal Articles

Long-Term Results of Single-Agent Thalidomide as Initial Therapy for Asymptomatic (Smoldering or Indolent) Myeloma.

Suzanne Hayman, MD, Morie Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Rafael Fonseca, MD, Susan Geyer, PhD, Shaji Kumar, MD, Steven Zeldenrust, MD, Stephen Russell, MD, PhD, John Lust, MD, PhD, Robert Kyle, MD, Philip Greipp, MD, Thomas Witzig, MD, S. Vincent Rajkumar, MD

Blood (2006) 108 (11): 3568.

https://doi.org/10.1182/blood.V108.11.3568.3568

Published: 2006

Journal Articles

Autologous Stem Cell Transplantation for Multiple Myeloma in Patients with Reduced Renal Function: A Matched Set Comparison.

Shaji Kumar, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Nelson Leung, MD, Vincent Rajkumar, MD, Steven Zeldenrust, MD, John Lust, MD, Philip Greipp, MD, Dennis Gastineau, MD, Morie Gertz, MD

Blood (2006) 108 (11): 3091.

https://doi.org/10.1182/blood.V108.11.3091.3091

Published: 2006

Journal Articles

Thymoglobulin (Polyclonal Rabbit Anti Thymocyte Globulin) Has In Vivo Activity in a Mouse Model of Myeloma.

Michael Timm, Linda Wellik, Teresa Kimlinger, Jessica Haug, Michael Kline, Ph.D, S. Vincent Rajkumar, MD, Philip Greipp, MD, Shaji Kumar, MD

Blood (2006) 108 (11): 3487.

https://doi.org/10.1182/blood.V108.11.3487.3487

Published: 2006

Journal Articles

Lenalidomide Plus Dexamethasone (Rev/Dex) in Newly Diagnosed Myeloma: Response to Therapy, Time to Progression, and Survival.

Martha Lacy, MD, Morie Gertz, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Susan Geyer, PhD, Steven Zeldenrust, MD, Shaji Kumar, MD, Philip Greipp, MD, Rafael Fonseca, MD, John Lust, MD, Stephen Russell, MD, PhD, Robert Kyle, MD, Thomas Witzig, MD, Leif Bergsagel, MD, S. Vincent Rajkumar, MD

Blood (2006) 108 (11): 798.

https://doi.org/10.1182/blood.V108.11.798.798

Published: 2006

Journal Articles

A Randomized Phase III Trial of Lenalidomide Plus High-Dose Dexamethasone Versus Lenalidomide Plus Low-Dose Dexamethasone in Newly Diagnosed Multiple Myeloma (E4A03): A Trial Coordinated by the Eastern Cooperative Oncology Group.

S. Vincent Rajkumar, MD, Susanna Jacobus, MS, Natalie Callander, MD, Rafael Fonseca, MD, David Vesole, MD, Philip Greipp, MD

Blood (2006) 108 (11): 799.

https://doi.org/10.1182/blood.V108.11.799.799

Published: 2006

Journal Articles

Cancer/Testis Antigen Profiling in Multiple Myeloma Define a Cohort of Patients with Poor Prognosis Regardless of Genetic Subtypes.

Wee-Joo Chng, MD, Natalia Gonzalez-Paz, MD, Shaji Kumar, MD, Scott Van Wier, Gregory Ahmann, Tammy Price-Troska, Kim Henderson, Marta Chesi, PhD, Morie Gertz, MD, S. Vincent Rajkumar, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Robert Kyle, MD, Philip Greipp, MD, Rafael Fonseca, MD, Peter Leif Bergsagel, MD

Blood (2005) 106 (11): 3381.

https://doi.org/10.1182/blood.V106.11.3381.3381

Published: 2005

Journal Articles

Genomic Analysis of High Hyperdiploid Acute Lymphoblastic Leukemia and Hyperdiploid Multiple Myeloma Suggests Differential Gene Dosage Effect on Expression and Provide Clues to Preferential Selection of Recurrently Trisomic Chromosomes.

Wee-Joo Chng, MD, Scott Van Wier, Gregory Ahmann, Tammy Price-Troska, Kim Henderson, Marta Chesi, PhD, Morie Gertz, MD, S. Vincent Rajkumar, MD, Robert Kyle, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Philip Greipp, MD, Peter Leif Bergsagel, MD, Rafael Fonseca, MD

Blood (2005) 106 (11): 3006.

https://doi.org/10.1182/blood.V106.11.3006.3006

Published: 2005

Journal Articles

Gene Expression Profiling Identifies 4 Sub-Classes with Distinct Clinical Associations in Hyperdiploid Myeloma.

Wee-Joo Chng, MD, Natalia Gonzalez-Paz, MD, Shaji Kumar, MD, Scott Van Wier, Gregory Ahmann, Tammy Price-Troska, Kim Henderson, Marta Chesi, PhD, Morie Gertz, MD, S. Vincent Rajkumar, MD, Robert Kyle, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Philip Greipp, MD, Peter Leif Bergsagel, MD, Rafael Fonseca, MD

Blood (2005) 106 (11): 1537.

https://doi.org/10.1182/blood.V106.11.1537.1537

Published: 2005

Journal Articles

Gene Expression Profiling of Hyperdiploid Multiple Reveal Complex Gene Dosage Effects and an mRNA Translation/Protein Synthesis Signature.

Wee-Joo Chng, MD, Scott Van Wier, Gregory Ahmann, Tammy Price-Troska, Kim Henderson, Marta Chesi, PhD, Tae-Hoon Chung, Seungchan Kim, PhD, John Carpten, PhD, Morie Gertz, MD, S. Vincent Rajkumar, MD, Martha Lacy, MD, Robert Kyle, MD, Philip Greipp, MD, Angela Dispenzieri, MD, Peter Leif Bergsagel, MD, Rafael Fonseca, MD

Blood (2005) 106 (11): 1538.

https://doi.org/10.1182/blood.V106.11.1538.1538

Published: 2005

Journal Articles

Compendium of Karyotypic Abnormalities and Their Clinical Implications in Hyperdiploid Multiple Myeloma (H-MM).

Wee-Joo Chng, MD, Scott Van Wier, Gregory Ahmann, Rafael Santana-Davila, MD, Syed Jalal, PhD, Rhett Ketterling, MD, Peter Leif Bergsagel, MD, Marta Chesi, PhD, Mike Trendle, MD, Martin Oken, MD, Emily Blood, Kim Henderson, Robert Kyle, MD, Morie Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Philip Greipp, MD, Rafael Fonseca, MD

Blood (2005) 106 (11): 1539.

https://doi.org/10.1182/blood.V106.11.1539.1539

Published: 2005

Journal Articles

Low Level Amplification (Duplication) of 1q21 in Myeloma and Prognosis; the Role of CKS1B.

Rafael Fonseca, MD, Scott Van Wier, Wee-Joo Chng, MD, Rhett Ketterling, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Peter Leif Bergsagel, MD, S. Vincent Rajkumar, MD, Philip Greipp, MD, Mark Litzow, MD, Shaji Kumar, MD, Natalia Gonzalez-Paz, MD, Kim Henderson, Gregory Ahmann, Morie Gertz, MD

Blood (2005) 106 (11): 624.

https://doi.org/10.1182/blood.V106.11.624.624

Published: 2005

Journal Articles

Role of the Chemokine Receptor CXCR4 in Waldenstrom Macroglobulinemia.

Irene M. Ghobrial, MD, Mona Melhem, MD, Ujjal Singha, PhD, Diane George, Michael Timm, MD, Lanie Francis, MD, Yazan Alsayed, MD, Alissa Huston, MD, G. David Roodman, MD, PhD, Philip Greipp, MD, Morie Gertz, MD, Thomas Witzig, MD

Blood (2005) 106 (11): 993.

https://doi.org/10.1182/blood.V106.11.993.993

Published: 2005

Journal Articles

One Half of Patients with Waldenström Macroglobulinemia Have Large Deletions of Chromosome 6q.

Scott Van Wier, BS, Wee-Joo Chng, MD, Greg Ahmann, BS, Rachel Rempel, BS, Azzah Al Masri, Ph.D, Morie Gertz, MD, Angela Dispenzieri, MD, Philip Greipp, MD, Roelandt F.J. Schop, MD, Rafael Fonseca, MD

Blood (2005) 106 (11): 1546.

https://doi.org/10.1182/blood.V106.11.1546.1546

Published: 2005

NARROW

Activation of MYC Pathway Is a Unifying Pathological Event in the Progression from Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma (MM).

A Randomized Trial of Lenalidomide Plus High-Dose Dexamethasone (RD) Versus Lenalidomide Plus Low-Dose Dexamethasone (Rd) in Newly Diagnosed Multiple Myeloma (E4A03): A Trial Coordinated by the Eastern Cooperative Oncology Group.

Combined High Resolution Array Comparative Genomic Hybridization and Gene Expression Profiling Reveal Rb1 Haploinsufficiency as a Possibile Tumorigenic Mechanism in Myeloma.

High Resolution Array CGH Identifies TRAF3 as a Novel Tumor Suppressor in Multiple Myeloma.

Long-Term Results of Single-Agent Thalidomide as Initial Therapy for Asymptomatic (Smoldering or Indolent) Myeloma.

Autologous Stem Cell Transplantation for Multiple Myeloma in Patients with Reduced Renal Function: A Matched Set Comparison.

Thymoglobulin (Polyclonal Rabbit Anti Thymocyte Globulin) Has In Vivo Activity in a Mouse Model of Myeloma.

Lenalidomide Plus Dexamethasone (Rev/Dex) in Newly Diagnosed Myeloma: Response to Therapy, Time to Progression, and Survival.

A Randomized Phase III Trial of Lenalidomide Plus High-Dose Dexamethasone Versus Lenalidomide Plus Low-Dose Dexamethasone in Newly Diagnosed Multiple Myeloma (E4A03): A Trial Coordinated by the Eastern Cooperative Oncology Group.

Cancer/Testis Antigen Profiling in Multiple Myeloma Define a Cohort of Patients with Poor Prognosis Regardless of Genetic Subtypes.

Genomic Analysis of High Hyperdiploid Acute Lymphoblastic Leukemia and Hyperdiploid Multiple Myeloma Suggests Differential Gene Dosage Effect on Expression and Provide Clues to Preferential Selection of Recurrently Trisomic Chromosomes.

Gene Expression Profiling Identifies 4 Sub-Classes with Distinct Clinical Associations in Hyperdiploid Myeloma.

Gene Expression Profiling of Hyperdiploid Multiple Reveal Complex Gene Dosage Effects and an mRNA Translation/Protein Synthesis Signature.

Compendium of Karyotypic Abnormalities and Their Clinical Implications in Hyperdiploid Multiple Myeloma (H-MM).

Low Level Amplification (Duplication) of 1q21 in Myeloma and Prognosis; the Role of CKS1B.

Role of the Chemokine Receptor CXCR4 in Waldenstrom Macroglobulinemia.

One Half of Patients with Waldenström Macroglobulinemia Have Large Deletions of Chromosome 6q.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only